Department of Urology, Pediatric Urology and Andrology, Medical Faculty of the, Justus Liebig University Giessen, Department of Dermatology, Venerology and Allergology, St. Josef-Hospital of the Medical Faculty, Ruhr-University Bochum, Medizinische Klinik und Poliklinik II, Justus-Liebig-Universität, Giessen, Department of Obstetrics and Gynecology of the Ludwig-Maximilians- Universität München, Institute for Medical Microbiology and Infection Control, Goethe University Frankfurt am Main.
Dtsch Arztebl Int. 2016 Jan 11;113(1-02):11-22. doi: 10.3238/arztebl.2016.0011.
The reported incidence of sexually transmitted infections (STIs) in Germany is rising. For example, the number of new reported cases of syphilis rose from 3034 in 2010 to 4410 in 2012.
This review is based on pertinent articles retrieved by a selective search in MEDLINE, and on guidelines and systematic reviews from Germany and abroad.
We discuss sexually transmitted infections presenting with genital, anal, perianal, or oral ulcers, urethritis, cervicitis, urethral or vaginal discharge, or genital warts. We also discuss sexually transmitted infection with HIV and the hepatitis C virus (HCV). Acquired sexually transmitted infections elevate the risk of transmission of other sexually transmitted infections; thus, patients presenting for the diagnosis or treatment of any kind of sexually transmitted infection should be evaluated for others as well. For most of these diseases, treatment of the patient's sexual partner(s) is indicated. Diagnostic nucleic acid amplification techniques are over 90% sensitive and specific and are generally the best way to detect the responsible pathogen. Factors impeding effective treatment include antibiotic resistance (an increasing problem) and the late diagnosis of HIV and HCV infections.
Sexually transmitted infections are common around the world, and any such infection increases the patient's risk of contracting other types of sexually transmitted infection. Molecular genetic diagnostic techniques should be made widely available.
德国报道的性传播感染(STIs)发病率正在上升。例如,梅毒的新报告病例数从 2010 年的 3034 例上升到 2012 年的 4410 例。
本综述基于在 MEDLINE 中进行选择性搜索获得的相关文章,以及德国和国外的指南和系统评价。
我们讨论了表现为生殖器、肛门、肛周或口腔溃疡、尿道炎、宫颈炎、尿道或阴道分泌物或生殖器疣的性传播感染。我们还讨论了与 HIV 和丙型肝炎病毒(HCV)相关的性传播感染。获得性性传播感染会增加传播其他性传播感染的风险;因此,任何一种性传播感染的诊断或治疗都应评估其他性传播感染。对于大多数这些疾病,患者的性伴侣(多个)需要接受治疗。诊断性核酸扩增技术的敏感性和特异性均超过 90%,是检测病原体的最佳方法。阻碍有效治疗的因素包括抗生素耐药性(日益严重的问题)以及 HIV 和 HCV 感染的晚期诊断。
性传播感染在全球范围内很常见,任何一种感染都会增加患者感染其他类型性传播感染的风险。应广泛提供分子遗传诊断技术。